No increas
Internal Medicine
2023-06-07

No increased risk of hypertension, pre-eclampsia after SARS-CoV-2 infection during pregnancy

Findings from a study published in BMJ Medicine showed no increased risk of hypertension during pregnancy or pre-eclampsia after infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) during pregnancy.  The study found that the results were similar for SARS-CoV-2 infection in any trimester, during times corresponding to the different dominant variants of the SARS-CoV-2, and when adjusting for vaccination status. “Severe COVID-19 has been shown to have multiorgan effects and symptomatology, similar to those seen in individuals with hypertension during pregnancy,” wrot...

Internal Medicine
2023-06-05

SGLT2i for evidence based cardiorenal protection in diabetic and non-diabetic chronic kidney di...

Chronic kidney disease (CKD) is a major public health issue affecting an estimated 850 million people globally. The leading causes of CKD is diabetes and hypertension, which together account for more than 50% of patients with end-stage kidney disease

Internal Medicine
2023-06-02

Robot-assisted Radical Cystectomy Versus Open Radical Cystectomy

CONTEXT Differences in recovery, oncological, and quality of life (QoL) outcomes between open radical cystectomy (ORC) and robot-assisted radical cystectomy (RARC) for patients with bladder cancer are unclear. OBJECTIVE This review aims to c...

Videos from category: Cardiology

Do overwei
6:30

Do overweight and obesity confer an additional risk of CAD in patients with FH?

EAS 2023
The Risk o
5:25

The Risk of Early Recurrent MI: What is the Role of Cholesterol Efflux and ApoA-I?

ACC 2023
Bempedoic
5:48

Bempedoic Acid Improves Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk

ACC 2023
How to inc
6:19

How to increase prescription of evidence-based therapies in adults with T2D and ASCVD? - The COORDINATE-Diabetes Study

ACC 2023

Videos from category: Diabetology

Targeting
9:22

Targeting CV risk factors with GLP-1 RAs in people with obesity

EASD 2022
Once weekl
7:36

Once weekly insulin: The ONWARDS 2 study

EASD 2022
Is HFpEF h
20:42

Is HFpEF hiding in your practice? Key messages of the DELIVER study: Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction

EASD 2022
Semaglutid
7:29

Semaglutide 2.4 mg improved glucose metabolism and reverted prediabetes to normoglycaemia in adults with overweight or obesity vs liraglutide 3.0 mg

EASD 2022

Videos from category: Hematology

LMWH use i
6:49

LMWH use in pregnancy: The Highlow and the ALPINE trial

ASH 2022
Novelties
8:35

Novelties in the treatment of myelofibrosis and polycythemia vera 2021

ASH 2021
Novelties
12:44

Novelties in the treatment of multiple myeloma 2021

ASH 2021
Risks for
5:01

Risks for Hospitalization and Death Among Patients with Blood Disorders from the ASH RC COVID-19 Registry for Hematology

ASH 2021

Videos from category: Internal Medicine

Anticoagul
8:47

Anticoagulant Advancements for VTE in Children

ISTH 2022
The Journe
3:15

The Journey to Address Unmet Needs Across all Haemophilia Indications

ISTH 2022
Clinical C
6:18

Clinical Challenges in Patients with Venous Thromboembolism

ISTH 2022
Good pract
19:37

Good practice statements for antithrombotic therapy in the management of COVID-19

ISTH 2022

Videos from category: Oncology

HER2 treat
12:07

HER2 treatment landscape 2023

ESMO Breast Cancer 2023
What's new
8:09

What's new in treatment of breast cancer? - Highlights of ESMO BC 2023

ESMO Breast Cancer 2023
Hot topics
15:11

Hot topics in melanoma management

EADO 2023
Functional
10:33

Functional Precision Medicine in Oncology

AACR 2023

Videos from category: Psychiatry

Current is
13:39

Current issues in the treatment of schizophrenia

EPA 2023
Highlights
10:47

Highlights of EPA 2023

EPA 2023
Novel Phar
8:13

Novel Pharmacotherapeutic Strategies for Regaining Control over Alcohol Intake in Alcohol Use Disorder

EPA 2021
Obstetric
6:010

Obstetric Complications: The Forgotten Risk Factor for Schizophrenia

EPA 2021

Videos from category: Respiratory

Choices in
10:06

Choices in asthma and COPD care: How to maximize outcomes for patients

ERS 2022
The digita
11:38

The digital age: The future of respiratory medicine

ERS 2021
ERS/EAACI
8:50

ERS/EAACI statement on adherence to international adult asthma guidelines

ERS 2021
Pulmonary
7:05

Pulmonary hypertension and interstitial pulmonary fibrosis

ERS 2021

Sixty Seconds Science

0:54
Do overweight and obesity confer an additional risk of CAD in patients with FH?
1:17
Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer
1:17
The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA
1:15
The issue of adjuvant vs neoadjuvant treatment
1:19
The treatment sequence in metastatic melanoma
1:12
LMWH use in pregnancy: The ALPINE trial
1:19
Functional Precision Medicine in Oncology
1:10
The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator
1:18
Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease

Spotify episodes

Apple podcasts

Google podcasts

Search by Scientific Content
Search by Congress
Search:
Date
Filters:
HER2 treat
12:07
Title Description

HER2 treatment landscape 2023

Presenter: Javier Cortes
Oncology : Breast Cancer
ESMO Breast Cancer 2023
Do overwei
6:30
Title Description

Do overweight and obesity confer an additional risk of CAD in patients with FH?

Presenter: Amany Elshorbagy
Cardiology : Atherosclerosis
EAS 2023
Objective
6:01
Title Description

Objective assessement of skin disease severity with the help of AI

Presenter: Maksym Breslavets
Dermatology
EADV Symposium 2023
What's new
8:09
Title Description

What's new in treatment of breast cancer? - Highlights of ESMO BC 2023

Presenter: Matteo Lambertini
Oncology : Breast Cancer
ESMO Breast Cancer 2023
Hot topics
15:11
Title Description

Hot topics in melanoma management

Presenter: Paolo A. Ascierto
Oncology
EADO 2023
Functional
10:33
Title Description

Functional Precision Medicine in Oncology

Presenter: Anthony Letai
Oncology
AACR 2023
The first
14:14
Title Description

The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator

Presenter: Jeffrey Weber
Oncology
AACR 2023
Current is
13:39
Title Description

Current issues in the treatment of schizophrenia

Presenter: Istvan Bitter
Psychiatry
EPA 2023
Highlights
10:47
Title Description

Highlights of EPA 2023

Presenter: Peter Falkai
Psychiatry
EPA 2023
The Risk o
5:25
Title Description

The Risk of Early Recurrent MI: What is the Role of Cholesterol Efflux and ApoA-I?

Presenter: Eliot A. Brinton
Cardiology
ACC 2023
Bempedoic
5:48
Title Description

Bempedoic Acid Improves Cardiovascular Outcomes In Statin Intolerant Patients At High Cardiovascular Risk

Presenter: Eliot A. Brinton
Cardiology
ACC 2023
How to inc
6:19
Title Description

How to increase prescription of evidence-based therapies in adults with T2D and ASCVD? - The COORDINATE-Diabetes Study

Presenter: Neha Pagidipati
Cardiology
ACC 2023
The FREEDO
6:42
Title Description

The FREEDOM COVID Anticoagulation Strategy Randomized Trial

Presenter: Gregg Stone
Cardiology
ACC 2023
Minimally
7:09
Title Description

Minimally Invasive Versus Conventional Sternotomy For Mitral Valve Repair Surgery - UK Mini Mitral Trial

Presenter: Enoch Akowuah
Cardiology
ACC 2023
Can Patien
3:56
Title Description

Can Patients with Hypertrophic Cardiomyopathy do Vigorous Exercise? - A Multinational Lifestyle And Exercise Study

Presenter: Rachel Lampert
Cardiology
ACC 2023
Efficacy a
3:31
Title Description

Efficacy and Safety of Oral PCSK9 Inhibitor, MK-0616 in the Treatment of Hypercholesterolemia

Presenter: Eliot A. Brinton
Cardiology
ACC 2023

Lectures

Carfilzomi
6:49

Carfilzomib, Dexamethasone, and Daratumumab Versus Carfilzomib and Dexamethasone for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma (RRMM): Primary Analysis Results from the Randomized, Open-Label, Phase 3 Study Candor

Presenter: Saad Z. Usmani
Hematology
Inhibition
6:22

Inhibition of Complement C1s with Sutimlimab in Patients with Cold Agglutinin Disease: Results from the Phase 3 Cardinal Study

Presenter: Alexander Röth
Hematology
The QUAZAR
8:20

The QUAZAR AML-001 Maintenance Trial: Results of a Phase III International, Randomized, Double-Blind, Placebo-Controlled Study of CC-486 (Oral Formulation of Azacitidine) in Patients with Acute Myeloid Leukemia in First Remission

Presenter: Andrew H. Wei
Hematology
Validation
7:11

Validation of BCL11A As Therapeutic Target in Sickle Cell Disease: Results from the Adult Cohort of a Pilot/Feasibility Gene Therapy Trial Inducing Sustained Expression of Fetal Hemoglobin Using Post-Transcriptional Gene Silencing

Presenter: David A. Williams
Hematology
A Randomiz
4:40

A Randomized Phase 3 Trial of Blinatumomab Vs. Chemotherapy As Post-Reinduction Therapy in High and Intermediate Risk First Relapse of B-ALL in Children and Adolescents/Young Adults Demonstrates Superior Efficacy and Tolerability of Blinatumomab

Presenter: Patrick A. Brown
Hematology
CLARIFY -
7:07

CLARIFY - In stable coronary disease, patients with angina and prior myocardial infarction have a poor prognosis despite adherence to guideline recommanded therapies. Final 5-year results from the CLARIFY study

Presenter: Emmanuel Sorbets
Cardiology
SWEDEHEART
5:26

SWEDEHEART: Secondary prevention medication after coronary artery bypass surgery and long-term mortality: A longitudinal population-based study from the SWEDEHEART registry

Presenter: Erik Bjoerklund
Cardiology
ICD use in
4:31

ICD use in HF - Association between implantable cardioverter-defibrillator use for primary prevention and mortality: a prospective propensity-score matched study

Presenter: Benedikt Schrange
Cardiology
PURE: Impa
10:51

PURE: Impact of modifiable risk factors on cardiovascular disease and mortality

Presenter: Salim Yusuf
Cardiology
RAPIDTnT:
5:37

RAPIDTnT: A randomised trial of a 1-hour troponin T protocol in suspected acute coronary syndromes: the Rapid Assessment of Possible ACS In the emergency Department with high sensitivity Troponin T

Presenter: Derek Chew
Cardiology
ENTRUST-AF
7:45

ENTRUST-AF PCI - Edoxaban-based versus vitamin-K-antagonist-based anti-thrombotic regimen following successful coronary stenting in atrial fibrillation patients

Presenter: Andreas Goette
Cardiology
POPular Ge
6:51

POPular Genetics - Genotype-guided oral P2Y12-inhibition in patients with St-segment elevation myocardial infarction undergoing primary PCI : a randomized, open-label, multicenter trial

Presenter: Jurrien M. Ten Berg
Cardiology
Combined e
5:03

Combined effect of lower LDL-C and lower SBP on the lifetime risk od cardiovascular disease

Presenter: Brian A. Ference
Cardiology
AFIRE - Ri
4:47

AFIRE - Rivaroxaban monotherapy versus dual therapy in patients with atrial fibrillation and stable coronary artery disease

Presenter: Satoshi Yasuda
Cardiology
GALACTIC -
7:23

GALACTIC - Goal-directed AfterLoad Reduction in Acute Congestive Cardiac Decompensation: a randomized controlled trial

Presenter: Christian Eugen Mueller
Cardiology
Salt subst
5:16

Salt substitution and community-wide reduction in blood pressure and hypertension incidence

Presenter: J. Jaime Miranda
Cardiology
Do overwei
0:54
Title Description

Do overweight and obesity confer an additional risk of CAD in patients with FH?

Presenter: Amany Elshorbagy
Cardiology
Interrupti
1:17
Title Description

Interrupting Endocrine Therapy to Attempt Pregnancy after Breast Cancer

Presenter: Matteo Lambertini
Oncology
The Omega-
1:17
Title Description

The Omega-3 Mystery: New Evidence Supports the Therapeutic Value of EPA

Presenter: Eliot A. Brinton
Cardiology
The issue
1:15
Title Description

The issue of adjuvant vs neoadjuvant treatment

Presenter: Paolo A. Ascierto
Oncology
The treatm
1:19
Title Description

The treatment sequence in metastatic melanoma

Presenter: Paolo A. Ascierto
Oncology
LMWH use i
1:12
Title Description

LMWH use in pregnancy: The ALPINE trial

Presenter: Saskia Middeldorp
Hematology
Functional
1:19
Title Description

Functional Precision Medicine in Oncology

Presenter: Anthony Letai
Oncology
The first
1:10
Title Description

The first mRNA cancer vaccine with pembrolizumab minimizes recurrence rate in melanoma tells Jeffrey Weber clinical investigator

Presenter: Jeffrey Weber
Oncology
Elevated L
1:18
Title Description

Elevated Lipoprotein(a) as a Risk Enhancing Factor for Atherosclerotic Cardiovascular Disease

Presenter: Nathan D. Wong
Cardiology
Long-term
8:46
Title Description

Long-term efficacy and safety of ixekizumab

Presenter: Andrew Blauvelt
Dermatology
Paradigm s
12:05
Title Description

Paradigm shift in the early NSCLC? The role of ICIs in the adjuvant treatment

Presenter: Federico Cappuzzo
Oncology
How will t
9:43
Title Description

How will the current therapeutic options change the treatment of RCC in the daily practice?

Presenter: Camillo Porta
Oncology
The role o
5:58
Title Description

The role of immune checkpoint inhibitors and VEGF TKIs in the adjuvant treatment of renal cell carcinoma

Presenter: David F. McDermott
Oncology
Treatment
11:50
Title Description

Treatment intensification in the treatment of prostate cancer

Presenter: Oliver Sartor
Oncology
Pembrolizu
16:35
Title Description

Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma

Presenter: Stefan N. Symeonides
Oncology
State of t
6:13
Title Description

State of the art treatment of bladder cancer

Presenter: Matthew R. Zibelman
Oncology